Inflation to skyrocket in April 2024
11 Jan 2024 10:19
Inflation in April 2024 will soar compared to February and May 2024.
CMRY recorded profit IDR 966.65 billion
27 Oct 2023 17:59
PT Cisarua Mountain Dairy Tbk (CMRY) posted a profit for the current period of IDR 966.65 billion in the third quarter of 2023, up from the same period in 2022 of IDR 878.61 billion.
BSDE booked marketing sales of IDR 6.75 trillion in Q3 2023
23 Oct 2023 17:16
PT Bumi Serpong Damai Tbk (BSDE) recorded marketing sales of IDR 6.75 trillion at the end of the third quarter (Q3) of 2023.
DFAM projects revenue decline
03 Oct 2023 13:55
PT Dafam Property Indonesia Tbk (DFAM) is correcting its revenue target by the end of this year following the slowing down of housing sales and rents.
Boy Thohir optimistic ADRO will achieve 2023 sales volume target
09 Aug 2023 15:15
Presiden Direktur dan Chief Executive Officer PT Adaro Energy Indonesia Tbk. ( ADRO) Garibaldi Thohir menyatakan optimistis terhadap target volume penjualan batu bara tahun 2023 ini. Hal itu menyusul dicapainya volume produksi sebesar 33,41 juta ton pada Semester I-2023, naik 19% dari 28,02 juta ton.
INCO profit grows 12%
28 Jul 2023 05:42
PT Vale Indonesia Tbk (INCO) posted a profit of US$ 168.51 million, growing 12% from the same period last year of US$ 150.45 million.
PEVE to open Megmart, boosting retail sales
24 Jul 2023 10:10
PT Penta Valent Tbk (PEVE), a pharmaceutical product distributor, introduces Megamart, a retail sales outlet, in order to expand its distribution network and raise revenue.
H1 2023 ended, BSDE scored marketing sales of IDR 4.7 trillion
20 Jul 2023 15:32
PT Bumi Serpong Damai Tbk (BSDE) collected marketing sales of IDR 4.79 trillion in the first half (H1) of 2023
BI Survey: retail sales expected to decline in July 2023
13 Jun 2023 11:33
Retail sales are predicted to decrease come July and October 2023, following the delayed domestic demand and the ending of discount programs.
Pyridam scored IDR 275.47 billion of profit
06 Apr 2023 18:05
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company, gained IDR 275.47 billion of net profit in 2022, proliferating 4,928% year-on-year (yoy) from IDR 5.47 billion in 2021.